Task: Answer the multiple-choice question.
Query: Which drug exhibits a -20.065% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CCC(=O)c1ccc(OCC(O)Cn2nnc3ccccc32)cc1
(b) CSCCC(N=Cc1c(O)n(-c2ccc(Br)cc2)c(=O)[nH]c1=O)C(=O)OC(C)(C)C
(c) O=c1[nH]c2ccsc2c(=O)n1CCO
Answer: a. CCC(=O)c1ccc(OCC(O)Cn2nnc3ccccc32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)c1ccc(OCC(O)Cn2nnc3ccccc32)cc1
CCC(=O)c1ccc(OCC(O)Cn2nnc3ccccc32)cc1
1-[4-[3-(benzotriazol-1-yl)-2-hydroxypropoxy]phenyl]propan-1-one